NCT00424203 - Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

November 30, 2011

Conditions

Breast CancerCognitive/Functional EffectsDepressionMalnutritionPsychosocial Effects of Cancer and Its Treatment

Interventions

DRUG

AC regimen

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

PROCEDURE

adjuvant therapy

PROCEDURE

cognitive assessment

PROCEDURE

management of therapy complications

PROCEDURE

psychosocial assessment and care

PROCEDURE

quality-of-life assessment

Trial Locations (17)

13273

Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille

31052

Institut Claudius Regaud, Toulouse

33076

Institut Bergonie, Bordeaux

35042

Centre Eugene Marquis, Rennes

44805

Centre Regional Rene Gauducheau, Nantes-Saint Herblain

49036

Centre Paul Papin, Angers

51056

Institut Jean Godinot, Reims

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

60309

C.H. Senlis, Senlis

63011

Centre Jean Perrin, Clermont-Ferrand

69373

Centre Leon Berard, Lyon

75015

Hopital Europeen Georges Pompidou, Paris

75248

Institut Curie Hopital, Paris

76038

Centre Henri Becquerel, Rouen

84082

Institut Sainte Catherine, Avignon

92211

Centre Rene Huguenin, Saint-Cloud

92309

Hopital Perpetuel Secours, Levallois-Perret

All Listed Sponsors

lead

UNICANCER

OTHER